Literature DB >> 30783772

Invasion of a murine in vitro blood-brain barrier co-culture model by dengue virus serotypes 1 to 4.

Fakhriedzwan Idris1,2, Siti Hanna Muharram3, Zainun Zaini4, Sylvie Alonso5, Suwarni Diah3.   

Abstract

The blood-brain barrier (BBB) is a physical barrier that restricts the passage of cells and molecules as well as pathogens into the central nervous system (CNS). Some viruses enter the CNS by disrupting the BBB, while others can reach the CNS without altering the integrity of the BBB. Even though dengue virus (DENV) is not a distinctive neurotropic virus, the virus is considered to be one of the leading causes of neurological manifestations. In this study, we found that DENV is able to compromise the integrity of a murine in vitro blood-brain barrier (BBB) model, resulting in hyperpermeability, as shown by a significant increase in sucrose and albumin permeability. Infection of brain endothelial cells (ECs) was facilitated by the presence of glycans, in particular, mannose and N-acetyl glucosamine residues, on cell surfaces and viral envelope proteins, and the requirement for glycan moieties for cell infection was serotype-specific. Direct viral disruption of brain ECs was observed, leading to a significant decrease in tight-junction protein expression and peripheral localization, which contributed to the changes in BBB permeability. In conclusion, the hyperpermeability and breaching mechanism of BBB by DENV are primarily due to direct consequences of viral infection of ECs, as shown in this in vitro study.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30783772     DOI: 10.1007/s00705-019-04175-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  2 in total

1.  Tree Shrew as a New Animal Model for the Study of Dengue Virus.

Authors:  Liming Jiang; Caixia Lu; Qiangming Sun
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

Review 2.  Neurological Symptoms of COVID-19: The Zonulin Hypothesis.

Authors:  Sílvia Llorens; Eduardo Nava; Mónica Muñoz-López; Álvaro Sánchez-Larsen; Tomás Segura
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.